496 related articles for article (PubMed ID: 34452519)
1. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
[TBL] [Abstract][Full Text] [Related]
2. Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.
Castellarnau A; Heery GP; Seta A; Luscombe CA; Kinghorn GR; Button P; McCloud P; Paull JRA
Sci Rep; 2022 Jun; 12(1):10210. PubMed ID: 35715644
[TBL] [Abstract][Full Text] [Related]
3. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
[TBL] [Abstract][Full Text] [Related]
4. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
[TBL] [Abstract][Full Text] [Related]
5. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
6. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
7. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.
Fumagalli V; Ravà M; Marotta D; Di Lucia P; Laura C; Sala E; Grillo M; Bono E; Giustini L; Perucchini C; Mainetti M; Sessa A; Garcia-Manteiga JM; Donnici L; Manganaro L; Delbue S; Broccoli V; De Francesco R; D'Adamo P; Kuka M; Guidotti LG; Iannacone M
Sci Immunol; 2022 Jan; 7(67):eabl9929. PubMed ID: 34812647
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
9. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
11. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.
Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Seibert B; Rajao DS; Wang J; Perez DR
Sci Rep; 2021 May; 11(1):9609. PubMed ID: 33953295
[TBL] [Abstract][Full Text] [Related]
13. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
14. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
15. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
[TBL] [Abstract][Full Text] [Related]
16. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.
Amruta N; Engler-Chiurazzi EB; Murray-Brown IC; Gressett TE; Biose IJ; Chastain WH; Befeler JB; Bix G
Life Sci; 2021 Nov; 284():119881. PubMed ID: 34389403
[TBL] [Abstract][Full Text] [Related]
17. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
19. Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model.
Romanowski EG; Yates KA; Paull JRA; Heery GP; Shanks RMQ
Molecules; 2021 Jun; 26(11):. PubMed ID: 34198721
[TBL] [Abstract][Full Text] [Related]
20. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]